SHP Wealth Management’s Alto Neuroscience ANRO Stock Holding History
Bought
Maintained
Sold
Other funds holding ANRO
AWG
CC
VPC
PA
SSC
VCM
VC
AC
SHP Wealth Management's ANRO Position: Q1 2026 in Review
SHP Wealth Management held its Alto Neuroscience (ANRO) position steady in Q1 2026 at 25 shares worth $562. The position accounts for ﹤0.01% of the portfolio, ranked #1601.
SHP Wealth Management first reported a position in ANRO in Q4 2025 and has held it in 2 quarters since. 110 funds tracked by Wall St. Rank hold ANRO as of Q1 2026.
- SHP Wealth Management held 25 shares of Alto Neuroscience worth $562 as of Q1 2026.
- SHP Wealth Management left its Alto Neuroscience share count unchanged in Q1 2026.
- Alto Neuroscience made up ﹤0.01% of SHP Wealth Management's portfolio in Q1 2026, its #1601 holding.
- SHP Wealth Management first reported a position in Alto Neuroscience in Q4 2025 and has held it in 2 quarters since.
- 110 funds tracked by Wall St. Rank held Alto Neuroscience as of Q1 2026.
Based on SHP Wealth Management's 13F filing for Q1 2026, filed 8 May 2026.